Dobutamine thallium myocardial perfusion tomography

Institute of Nuclear Medicine, University College and Middlesex School of Medicine, London, England.

Dobutamine has favorable properties for the pharmacologic manipulation of myocardial oxygen demand in the provocation of ischemia during the investigation of coronary artery disease. The value of dobutamine infusion for thallium myocardial perfusion tomography was assessed in 50 patients with exertional chest pain undergoing coronary arteriography. Dobutamine was infused in 5-min stages at incremental rates from 5 to 20 micrograms/kg per min or until limited by symptoms. The myocardium was divided into nine segments for analysis of perfusion. Thirty-nine of 40 patients with coronary artery disease had a reversible perfusion defect demonstrated by dobutamine thallium tomography (sensitivity 97%) and 8 of 10 patients with normal coronary arteries had normal myocardial perfusion (specificity 80%). These values were significantly better than the sensitivity and specificity of exercise electrocardiography (78% and 44%, respectively; p less than 0.01). There was a significant relation between the mean number of segments with abnormal perfusion and the number of diseased coronary vessels (0.6, 2.6, 4.4 and 6 segments in zero-, one-, two- and three-vessel disease, respectively; p less than 0.001). There was also a significant relation between the maximal tolerated dose of dobutamine and the treadmill exercise time (r = 0.56, p less than 0.001), but a wide range of exercise times was achieved in the 15- and 20-micrograms/kg per min groups, principally because of exercise limitation by noncardiac symptoms. Dobutamine infusion was well tolerated in all patients, including six with asthma. There were no significant arrhythmias or limiting symptoms other than chest pain.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				C Y Loong and C Anagnostopoulos Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging Heart, August 1, 2004; 90(suppl_5): v2 - v9. [Full Text] [PDF]

				A. Elhendy, J. J. Bax, and D. Poldermans Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease J. Nucl. Med., December 1, 2002; 43(12): 1634 - 1646. [Abstract] [Full Text] [PDF]

				F. Saremi, H. Jadvar, and M. E. Siegel Pharmacologic Interventions in Nuclear Radiology: Indications, Imaging Protocols, and Clinical Results RadioGraphics, May 1, 2002; 22(3): 477 - 490. [Abstract] [Full Text] [PDF]

				M. L. Geleijnse, A. Elhendy, P. M. Fioretti, and J. R. T. C. Roelandt Dobutamine stress myocardial perfusion imaging J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2017 - 2027. [Abstract] [Full Text] [PDF]

				A. Elhendy, R. T. van Domburg, J. J. Bax, R. Valkema, A. E. M. Reijs, E. P. Krenning, and J. R. T. C. Roelandt Safety, Hemodynamic Profile, and Feasibility of Dobutamine Stress Technetium Myocardial Perfusion Single-Photon Emission CT Imaging for Evaluation of Coronary Artery Disease in the Elderly Chest, March 1, 2000; 117(3): 649 - 656. [Abstract] [Full Text] [PDF]

				D. A. Calnon, M. Ruiz, G. Vanzetto, D. D. Watson, G. A. Beller, and D. K. Glover Myocardial Uptake of 99mTc-N-NOET and 201Tl During Dobutamine Infusion : Comparison With Adenosine Stress Circulation, October 12, 1999; 100(15): 1653 - 1659. [Abstract] [Full Text] [PDF]

				A. Elhendy, R. T. van Domburg, J. J. Bax, and J. R. T. C. Roelandt The significance of stress-induced ST segment depression in patients with inferior Q wave myocardial infarction J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1909 - 1915. [Abstract] [Full Text] [PDF]

				R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF]

				R S Khattar, R Senior, and A Lahiri Assessment of myocardial perfusion and contractile function by inotropic stress Tc-99m sestamibi SPECT imaging and echocardiography for optimal detection of multivessel coronary artery disease Heart, March 1, 1998; 79(3): 274 - 280. [Abstract] [Full Text]

				Y. Genma, S. Ogawa, J. Zhang, and M. Yamamoto Evaluation of myocardial ischemia in Kawasaki disease by dobutamine stress signal-averaged ventricular late potentials Cardiovasc Res, December 1, 1997; 36(3): 323 - 329. [Abstract] [Full Text] [PDF]

				R. M. Fleming, C. H. Rose, and K. M. Feldmann Comparing a High-Dose Dipyridamole SPECT Imaging Protocol with Dobutamine and Exercise Stress Testing Protocols Angiology, July 1, 1995; 46(7): 547 - 556. [Abstract] [PDF]